Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
暂无分享,去创建一个
S. Green | C. Osborne | B. Hoogstraten | S. Green | J. Athens | T. Maloney | S. Rivkin | H. Glucksberg | B. Metch | N. Gad‐el‐mawla | J. Constanzi | T. Maloney